Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.

@article{Espinosa2001RiskOD,
  title={Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.},
  author={Mario Espinosa and Alejandro Mart{\'i}n-Malo and Mar{\'i}a Antonia Alvarez de Lara and Pedro Aljama},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={2001},
  volume={16 8},
  pages={1669-74}
}
BACKGROUND Hepatitis C virus (HCV) infection is the most common cause of chronic liver disease in haemodialysis patients. The aim of this study was to assess the impact of HCV infection on patient survival in a cohort of long-term haemodialysis patients and to evaluate the percentage of anti-HCV-positive patients that evolve to liver cirrhosis. METHODS In 1992, 175 patients who had been on intermittent haemodialysis therapy for at least 6 months were included in the study (57 anti-HCV… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

Predictive Inflammatory Marker in HCV Positive Hemodialysis Patients

Hesham Abouellail, Sameh Abdelraouf, Haitham Ezzat Abdelaziz, Ahmed Moahmed Baha El-Dine
2015
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…